New Sanofi-GSK COVID Vaccine Highly Effective, Companies Say
WEDNESDAY, Feb. 23, 2022 (HealthDay News) — Two doses of a new COVID-19 vaccine from Sanofi and GSK were 100% effective against severe disease and hospitalizations, the companies announced Wednesday. The vaccine was also 75% effective against moderate-to-severe disease and 58% effective against symptomatic disease in a Phase 3 clinicalContinue Reading










